Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom

Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom's articles

  1. Pharmaceuticals and Drug Development

VU Researchers Publish Study on the Mechanism of CRISPR-Cas “Protein Scissors” in Molecular Cell

CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and functions. Among them, the most studied proteins today are Cas9 and Cas12, also known as DNA or gene ‘scissors’, which have revolutionized the field of genome editing, enabling scientists to […]
Written by
  1. Pharmaceuticals and Drug Development

Pioneer Group’s life sciences campuses host biggest Ada Lovelace Day event to date

The event was the seventh annual Ada Lovelace Day celebration run by Pioneer in collaboration with educational charity Ignite! and the biggest to date. The two-day event showcased the real-world impact of women in science through interactive workshops held at MediCity Nottingham, Kent Science Park, Wilton Centre, Hexagon Tower, BioCity Glasgow, BioCity Nottingham, Edinburgh Technopole, […]
Written by
  1. Pharmaceuticals and Drug Development

Discovery Park Ventures expands fund to £3m to invest in more innovative science and technology start-ups

Sandwich, Kent, UK, 4th December 2023 – Discovery Park Ventures (DPV) announces the expansion of its early-stage life science fund from £1m to £3m, in order to capitalise on exciting investment opportunities and support its existing portfolio. The fund’s investors have committed an additional £2m, which will also enable the fund to take larger stakes […]
Written by
  1. Pharmaceuticals and Drug Development

New protein linked to early-onset dementia identified

Scientists have identified abnormal aggregates of a protein called TAF15 in the brains of individuals with early-onset dementia, known as frontotemporal dementia, where the cause was not previously known.  Most neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these diseases, researchers have identified the proteins that aggregate, allowing them […]
Written by
  1. Pharmaceuticals and Drug Development

Vilnius University Scientists’ Research on Bacterial Defense from Viruses Was Published in Science

CRISPR-Cas systems provide interference against invading foreign nucleic acids by different mechanisms. In bacteria, several different types of antiviral CRISPR-Cas systems are found, which differ in Cas proteins and their functions. Currently, the best-known Cas9 and Cas12 proteins are widely used as genome editing tools. A team of researchers led by Gintautas Tamulaitis is studying […]
Written by
  1. Pharmaceuticals and Drug Development

New study from the RVC explores malaria invasion to help develop life-saving vaccine

Malaria is a deadly disease caused by the Plasmodium parasite which infects more than 200 million people a year, causing approximately 600,000 deaths annually worldwide with young children in Africa disproportionately affected. With numbers of infections expected to rise in the coming years due to growing parasite resistance to frontline anti-malarial drugs, there is a […]
Written by
  1. Pharmaceuticals and Drug Development

Lab Innovations 2024 to champion sustainability and innovation

Lab innovations 2024 has already hit the record numbers set by last year’s show, with 80% of last year’s 202 exhibitors booking stands again for this year. Many leading brands from the industry have been confirmed to exhibit, including Waters, Sartorius, Scientific Laboratory Supplies, Veolia Water Technologies, SciMed, Alpha Laboratories Limited, IKA, PerkinElmer, Integra Biosciences, […]
Written by
  1. Pharmaceuticals and Drug Development

Science present’s audio system carry star energy to the lab

Laboratory tools provider Scientific Laboratory Provides (SLS) has introduced the keynote audio system that guests to the SLS Present and Convention will get pleasure from on the East Midlands Convention Centre, Nottingham, on Could 22. Robin Ince, Dr Helen Czerski and Dr Adam Rutherford will every give shows in the principle lecture corridor. Drawing on […]
Written by
  1. Pharmaceuticals and Drug Development

SMR: THE INNOVATION LANDSCAPE – Drug Discovery Right now

As predicted by the distinguished audio system within the final assembly, we now have noticed great modifications within the life sciences sector; valuation readjustments, AI pushed R&D, M&As and financing challenges. These modifications within the panorama promise to introduce main steps ahead within the evolution of life sciences and a larger alternative for all stakeholders […]
Written by
  1. Pharmaceuticals and Drug Development

Groundbreaking treatment for Alcohol Use Disorder shown to halve alcohol consumption amongst heavy drinkers in three months at phase II: a new hope for patients

Orléans, France, 6 November 2023. Kinnov Therapeutics’ phase II study for its lead compound KT-110 has shown that the treatment can halve alcohol consumption amongst heavy drinkers in three months.    The multi-centre, randomised, double-blind, placebo-controlled Phase II clinical trial included 154 patients suffering from severe alcoholism and was conducted in 34 investigating centres across […]
Written by
  1. Pharmaceuticals and Drug Development

First wireless map of worm’s nervous system revealed

This huge step forward in understanding how neurons communicate through extremely short proteins called neuropeptides will help scientists understand how our emotions and mental states are controlled, as well as widespread neuropsychiatric conditions like eating disorders, OCD and PSTD.   The map, which details 31,479 neuropeptide interactions between the worm’s 302 neurons, shows where each neuropeptide, […]
Written by
  1. Pharmaceuticals and Drug Development

Cancer Research UK and the KWF Dutch Cancer Society enter partnership to bring multiple drugs into clinical development

Under the partnership, KWF intends to provide funding to enable the development of select early phase clinical programmes* through Cancer Research UK’s Centre for Drug Development (CDD). Cancer Research UK’s CDD will be utilising its 30 years of experience in ushering first-in-class and best-in-class therapeutics through the clinic to sponsor and manage KWF-supported trials as […]
Written by

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.